Endometrial preperation before hyteroscopic polypectomy endometrial preperation, endometrial polyp and hyteroscopic polypectomy
Conditions
Interventions
In the Dienogest group, patients will take tablets No. 1 to 14, each containing 2 mg of dienogest, with all tablets having identical content.,In the Estradiol plus Dienogest group, patients will take
Experimental Drug,Experimental Drug
Dienogest group,Estradiol plus Dienogest group
Sponsors
Bhulmibol Foundation
Obstetric and Gynecologic Department
Eligibility
Sex/Gender
Female
Age
15 Years to 55 Years
Inclusion criteria
Inclusion criteria: 1. Female patients of reproductive age who present with abnormal uterine bleeding, and who have had regular menstrual cycles for at least six months prior to the onset of abnormal bleeding. 2. The cause of abnormal uterine bleeding must be identified as an endometrial polyp measuring less than 2 centimeters in size. 3. Participants will undergo hysteroscopic surgery (hysteroscopic polypectomy) for removal of the polyp. The procedure will be performed exclusively by Dr. Paweena Phaliwong, M.D. 4. All participants are required to sign the informed consent form prior to enrollment in the study.
Exclusion criteria
Exclusion criteria: 1. Contraindications to taking either of the two medications: combined oral contraceptive pills and progestogen-only oral medication 2. History of allergy to any component of either medication 3. Inability to complete the full medication regimen as required by the study 4. Inability to communicate in or understand the Thai language
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Endometrial thickness 14 days Endometrial thickness measurement by ultrasound | — |
Secondary
| Measure | Time frame |
|---|---|
| the effectiveness of the two medications leads to differences in surgical outcomes During surgery The results of the operation | — |
Countries
Thailand
Contacts
Public ContactDr. Paweena Phaliwong
Bhulmibol Aduyaldej Hospital
Outcome results
None listed